B. Riley Securities Maintains Buy on Journey Medical, Lowers Price Target to $3
B. Riley Securities Maintains Buy on Journey Medical, Lowers Price Target to $3
B. Riley Securities維持對Journey Medical的買入，將目標股
B. Riley Securities analyst Kalpit Patel maintains Journey Medical (NASDAQ:DERM) with a Buy and lowers the price target from $6 to $3.
B. Riley Securities分析師卡爾皮特·帕特爾維持Journey Medical（納斯達克股票代碼：DERM）的買入，並將目標股價從6美元下調至3美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。